| Literature DB >> 18225426 |
Daniel Schirlin1, Martin Galvan, Gérard Le Fur.
Abstract
New lead-identification methodologies such as high-throughput screening and combinatorial chemistry have been integrated into pharmaceutical research over the past 5-10 years. More rational use in the selection of potential preclinical candidates for some difficult targets has increased the chances of success.Mesh:
Year: 2007 PMID: 18225426
Source DB: PubMed Journal: Bull Acad Natl Med ISSN: 0001-4079 Impact factor: 0.144